Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Famotidine poisoning |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Accidental famotidine poisoning (disorder) |
Causative agent |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Intentional famotidine poisoning |
Causative agent |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
forgiftning med famotidin, uvist med hvilken hensigt |
Causative agent |
False |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine adverse reaction |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Allergy to famotidine (finding) |
Causative agent |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Famotidine overdose |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Accidental famotidine overdose |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Intentional famotidine overdose |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
overdosis af famotidin, uvist med hvilken hensigt |
Causative agent |
False |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Famotidine 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Famotidine 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
famotidin 400 µg/ml injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Famotidine 8 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
famotidin 10 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
famotidin 10 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Product containing famotidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Accidental famotidine poisoning (disorder) |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Intentional famotidine poisoning |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing calcium carbonate and famotidine and magnesium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
|
Famotidine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Allergy to famotidine (finding) |
Causative agent |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 40 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 40 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Calcium carbonate and famotidine and magnesium hydroxide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only famotidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 10 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 8 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Famotidine 8 mg/mL oral suspension |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 20 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely famotidine 40 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only calcium carbonate and famotidine and magnesium hydroxide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Calcium carbonate 800 mg and famotidine 10 mg and magnesium hydroxide 165 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing only famotidine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Calcium carbonate- and famotidine- and magnesium hydroxide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |
Product containing famotidine in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Famotidine (substance) |
Inferred relationship |
Some |
1 |